Narrow- and Broad-Spectrum Antibiotic Use among U.S. Children

Eric M Sarpong1, G Edward Miller1

  • 1Division of Modeling and Simulation, Center for Financing, Access and Cost Trends, Agency for Healthcare Research and Quality, Rockville, MD.

Health Services Research
|November 27, 2014
PubMed

Insights

Over a quarter of U.S. children use antibiotics annually, with significant disparities in broad- and narrow-spectrum antibiotic use. Factors like health status, insurance, and race-ethnicity influence prescribing patterns for respiratory tract infections (RTIs).

Area of Science:

  • Pediatric infectious diseases
  • Pharmacoepidemiology
  • Health services research

Background:

  • Antibiotic resistance is a growing global health concern, necessitating careful monitoring of antibiotic use.
  • Understanding patterns of antibiotic prescribing in children is crucial for developing targeted interventions.
  • Previous studies have indicated variations in antibiotic use, but updated estimates are needed.

Purpose of the Study:

  • To provide current estimates of narrow- and broad-spectrum antibiotic consumption among children in the United States.
  • To examine the association between individual, family, and community factors and antibiotic use for respiratory tract infections (RTIs).

Main Methods:

  • Utilized linked, nationally representative data from the Medical Expenditure Panel Survey (2004-2010) and the 2000 Decennial Census.
  • Employed multinomial choice models to analyze relationships between characteristics and antibiotic use.
  • Investigated antibiotic use overall and specifically for the treatment of RTIs.

Main Results:

  • Annually, 27.3% of children used at least one antibiotic, with 12.8% using broad-spectrum and 18.5% using narrow-spectrum agents.
  • Over two-thirds (68.6%) of antibiotic use in children was for treating RTIs.
  • Significant differences in antibiotic use were observed across various demographic and socioeconomic groups, including age, health status, insurance, parental income/education, race-ethnicity, and Census region.

Conclusions:

  • Despite some reports of declining antibiotic use, substantial disparities persist among U.S. children.
  • Factors related to need, resources, race-ethnicity, and geographic region are strongly associated with differential antibiotic prescribing.
  • Further efforts are required to promote judicious and appropriate antibiotic prescribing for pediatric populations.
Abstract

Related Concept Videos

Antibiotic Selection00:57

Antibiotic Selection

Overview
62.5K
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
393
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
944
Mechanism of Antibiotic Resistance in MRSA01:25

Mechanism of Antibiotic Resistance in MRSA

Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and...
172
Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within...
66
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
895